ArticleInternational journal of environmental research and public health2022

Cost-Effectiveness and Cost-Utility of Palbociclib versus Ribociclib in Women with Stage IV Breast Cancer: A Real-World Data Evaluation.

Nour Hisham Al-Ziftawi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.